Summary
To estimate the efficacy of screening on colorectal cancer mortality, a population-based case–control study was conducted in well-defined areas of Burgundy (France). Screening by faecal occult blood test prior to diagnosis in cases born between 1914 and 1943 and who died of colorectal cancer diagnosed in 1988–94 was compared with screening in controls matched with the case for age, sex and place of residence. Cases were less likely to have been screened than controls, with an odds ratio (OR) of 0.67 [95% confidence interval (CI) 0.48–0.94]. The negative overall association did not differ by gender or by anatomical location. The odds ratio of death from colorectal cancer was 0.64 (95% CI 0.46–0.91) for those screened within 3 years of case diagnosis compared with those not screened. It was 1.14 (95% CI 0.50–2.63) for those screened more than 3 years before case diagnosis. There was a negative association between the risk of death from colorectal cancer and the number of participations in the screening campaigns. The inverse association between screening for faecal occult blood and fatal colorectal cancer suggests that screening can reduce colorectal cancer mortality. This report further supports recommendations for population-based mass screening with faecal occult blood test.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berrino, F., Sant, M., Verdecchia, A., Capocaccia, R., Hakulinen, T. & Estève, J. (1995). Survival of Cancer Patients in Europe? The EUROCARE Study, IARC scientific publications no. 132. IARC: Lyon
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H. E., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D. & Mangham, C. M. (1996). Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 348: 1472–1477.
Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O. D. & Sondergaard, O. (1996). Randomised study of screening for colorectal cancer with fecal occult blood test at Funen in Denmark. Lancet 348: 1467–1471.
Lazovich, D., Weiss, N. S., Stevens, N. G., White, E., McKnight, B. & Wagner, E. H. (1995). A case–control study to evaluate efficacy of screening for faecal occult blood. J Med Screening 2: 84–89.
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, M., Schuman, L. M. & Ederer, F. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328: 1365–1371.
Newcomb, P. A., Norfleet, R. G., Storer, B. E., Surawicz, T. & Marcus, P. M. (1992). Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84: 1572–1575.
Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L. & Young, J. (1997). Cancer Incidence in Five Continents, Vol. VII, IARC Scientific Publication no. 143. IARC: Lyon
Saito, H., Soma, Y., Koeda, J., Wada, T., Kawaguchi, H. & Sobue, T. (1995). Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case–control study. Int J Cancer 61: 465–469.
Selby, J. V., Friedman, G. D., Quesenberry, C. P. & Weiss, N. S. (1993). Effect of fecal occult blood testing on mortality from colorectal cancer. Ann Intern Med 118: 1–6.
Tazi, M. A., Faivre, J., Dassonville, F., Lamour, J., Milan, C. & Durand, G. (1997). Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen 4: 147–151.
Thomas, W. M., Pye, G., Hardcastle, J. D. & Walker, A. R. (1992). Screening for colorectal carcinoma: an analysis of the sensitivity of Haemoccult. Br J Surg 79: 833–835.
Warhendorf, J., Robra, B. P., Wiebelt, H., Oberhausen, R., Weiland, M. & Dhom, G. (1993). Effectiveness of colorectal cancer screening: results from a population-based case–control study in Saarland, Germany. Eur J Cancer Prev 2: 221–227.
Zappa, M., Castiglione, G., Grazzini, G., Falini, P., Giorgi, D., Paci, E. & Ciatto, S. (1997). Effect of faecal occult blood testing on colorectal mortality: result of a population-based case–control study in district of Florence, Italy. Int J Cancer 73: 208–210.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Faivre, J., Tazi, M., El Mrini, T. et al. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 79, 680–683 (1999). https://doi.org/10.1038/sj.bjc.6690107
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690107
Keywords
This article is cited by
-
The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference?
Digestive Diseases and Sciences (2015)
-
Bevolkingsonderzoek naar darmkanker
Bijblijven (2009)
-
Le dépistage du cancer colorectal Etat des connaissances, mise en place en France
Acta Endoscopica (2007)
-
Stratégies de dépistage du cancer colorectal: endoscopie versus autres modes d’exploration
Acta Endoscopica (2005)
-
Le déplstage du cancer colorectal par la recherche d'un saignement occulte dans les selles, dans la population à risque moyen
Acta Endoscopica (2002)